In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome

Back

EHRA Premium Access

In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome

Session: Basic Science

Topic: Ion Channels, Electrophysiology

Speaker: Ms L. Giammarino (Bern, CH)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Ms Lucilla Giammarino

University of Bern, Bern (Switzerland)

1 presentation

0 follower

6 more presentations in this session

Decreasing microtubule detyrosination by parthenolide restores sodium current in mdx cardiomyocytes

Speaker: Associate Professor C. Remme (Amsterdam, NL)

Etiological and molecular determinants of atrial endomysial fibrosis: results from the CATCH ME consortium

Speaker: Mr J. Winters (Maastricht, NL)

Exosome-mediated targeted delivery of NOX4 siRNA ameliorates angiotensin II-induced atrial fibrillation in mice

Speaker: Ms J. Kang (Seoul, KR)

Association between CHARGE-AF risk score and LA mechanics: LA reservoir strain can be a single parameter for predicting AF risk

In silico biatrial fibrosis ablation improves atrial fibrillation outcome

Speaker: Doctor C. Roney (London, GB)

Access the full session

Basic Science

Speakers: Ms L. Giammarino, Associate Professor C. Remme, Mr J. Winters, Ms J. Kang, Doctor C. Roney

Access

Video

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources